Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2001-01, Vol.81 (1), p.102-113
Hauptverfasser: Huang, Jau-Shyang, Guh, Jinn-Yuh, Chen, Hung-Chun, Hung, Wen-Chun, Lai, Yung-Hsiung, Chuang, Lea-Yea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113
container_issue 1
container_start_page 102
container_title Journal of cellular biochemistry
container_volume 81
creator Huang, Jau-Shyang
Guh, Jinn-Yuh
Chen, Hung-Chun
Hung, Wen-Chun
Lai, Yung-Hsiung
Chuang, Lea-Yea
description Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.
doi_str_mv 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70611811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70611811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</originalsourceid><addsrcrecordid>eNqVkd9u0zAUxiMEYmXwCshXaLtw5-O4cdIhpJCtZX-0Sl1RNW6OHMfpAmnSxSmjj8Eb46jZuOEGWZYt-zu_7-h8nncKbAiM8RNgkaQiEOKIMwZMMDgOYQwfgfHxOL44o5fJZ3eXn_whGyazU07vXniD56qX3oBJn1HuAz_w3lj7nTEWRT5_7R0AQNgBB97veV0aUuekMdps2rohudsq-6kqbTKyKndatUVdEVNldNPU2Va35GgeT8-Piaoy0t4bchlfndwu4gW1xapSZVGtyEa1949qR4qKOCktKlfncLouS7UyFelJHdhJbuZXVEQTok1Z2rfeq1yV1rzrz0Pv6-R8kXyh17PpRRJfUy0CKSmXWZRLrXKTp7mM0jAMR5BGQkZGQgApB55m3ICQYeZLaUwkhQrESI4E1yoc-Yfehz3X9fKwNbbFdWG7DlRl6q1FyQI3JQAnvN0LdVNb25gcN02xVs0OgWGXFHYzx27m-JQUhoBuuT90SWGfFPrIMJkhxztHfd_bb9O1yf4y-2icYLkXPBal2f2X578tn54cme7JhW3Nr2eyan5gIH05wuXNFBPGv03EMsDE_wMfMroS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70611811</pqid></control><display><type>article</type><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</creator><creatorcontrib>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</creatorcontrib><description>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/1097-4644(20010401)81:1&lt;102::AID-JCB1027&gt;3.0.CO;2-Y</identifier><identifier>PMID: 11180401</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>advanced glycation end-product ; Base Sequence ; captopril ; Captopril - pharmacology ; Cell Line ; Collagen - biosynthesis ; diabetic nephropathy ; DNA Primers ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Down-Regulation - drug effects ; Glycation End Products, Advanced ; Janus Kinase 2 ; Kinetics ; oligodeoxynucleotide ; Oligonucleotides, Antisense - pharmacology ; Phosphorylation ; Protein-Tyrosine Kinases - metabolism ; Proto-Oncogene Proteins ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - genetics ; Receptors, Immunologic - metabolism ; Signal Transduction ; STAT1 Transcription Factor ; STAT3 Transcription Factor ; Trans-Activators - metabolism ; Tyrosine - metabolism ; tyrosine phosphorylation ; Tyrphostins - pharmacology</subject><ispartof>Journal of cellular biochemistry, 2001-01, Vol.81 (1), p.102-113</ispartof><rights>Copyright © 2001 Wiley‐Liss, Inc.</rights><rights>Copyright 2001 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1097-4644%2820010401%2981%3A1%3C102%3A%3AAID-JCB1027%3E3.0.CO%3B2-Y$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1097-4644%2820010401%2981%3A1%3C102%3A%3AAID-JCB1027%3E3.0.CO%3B2-Y$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11180401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Jau-Shyang</creatorcontrib><creatorcontrib>Guh, Jinn-Yuh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><creatorcontrib>Hung, Wen-Chun</creatorcontrib><creatorcontrib>Lai, Yung-Hsiung</creatorcontrib><creatorcontrib>Chuang, Lea-Yea</creatorcontrib><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</description><subject>advanced glycation end-product</subject><subject>Base Sequence</subject><subject>captopril</subject><subject>Captopril - pharmacology</subject><subject>Cell Line</subject><subject>Collagen - biosynthesis</subject><subject>diabetic nephropathy</subject><subject>DNA Primers</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation - drug effects</subject><subject>Glycation End Products, Advanced</subject><subject>Janus Kinase 2</subject><subject>Kinetics</subject><subject>oligodeoxynucleotide</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Phosphorylation</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Signal Transduction</subject><subject>STAT1 Transcription Factor</subject><subject>STAT3 Transcription Factor</subject><subject>Trans-Activators - metabolism</subject><subject>Tyrosine - metabolism</subject><subject>tyrosine phosphorylation</subject><subject>Tyrphostins - pharmacology</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkd9u0zAUxiMEYmXwCshXaLtw5-O4cdIhpJCtZX-0Sl1RNW6OHMfpAmnSxSmjj8Eb46jZuOEGWZYt-zu_7-h8nncKbAiM8RNgkaQiEOKIMwZMMDgOYQwfgfHxOL44o5fJZ3eXn_whGyazU07vXniD56qX3oBJn1HuAz_w3lj7nTEWRT5_7R0AQNgBB97veV0aUuekMdps2rohudsq-6kqbTKyKndatUVdEVNldNPU2Va35GgeT8-Piaoy0t4bchlfndwu4gW1xapSZVGtyEa1949qR4qKOCktKlfncLouS7UyFelJHdhJbuZXVEQTok1Z2rfeq1yV1rzrz0Pv6-R8kXyh17PpRRJfUy0CKSmXWZRLrXKTp7mM0jAMR5BGQkZGQgApB55m3ICQYeZLaUwkhQrESI4E1yoc-Yfehz3X9fKwNbbFdWG7DlRl6q1FyQI3JQAnvN0LdVNb25gcN02xVs0OgWGXFHYzx27m-JQUhoBuuT90SWGfFPrIMJkhxztHfd_bb9O1yf4y-2icYLkXPBal2f2X578tn54cme7JhW3Nr2eyan5gIH05wuXNFBPGv03EMsDE_wMfMroS</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>Huang, Jau-Shyang</creator><creator>Guh, Jinn-Yuh</creator><creator>Chen, Hung-Chun</creator><creator>Hung, Wen-Chun</creator><creator>Lai, Yung-Hsiung</creator><creator>Chuang, Lea-Yea</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010101</creationdate><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><author>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>advanced glycation end-product</topic><topic>Base Sequence</topic><topic>captopril</topic><topic>Captopril - pharmacology</topic><topic>Cell Line</topic><topic>Collagen - biosynthesis</topic><topic>diabetic nephropathy</topic><topic>DNA Primers</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation - drug effects</topic><topic>Glycation End Products, Advanced</topic><topic>Janus Kinase 2</topic><topic>Kinetics</topic><topic>oligodeoxynucleotide</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Phosphorylation</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Signal Transduction</topic><topic>STAT1 Transcription Factor</topic><topic>STAT3 Transcription Factor</topic><topic>Trans-Activators - metabolism</topic><topic>Tyrosine - metabolism</topic><topic>tyrosine phosphorylation</topic><topic>Tyrphostins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Jau-Shyang</creatorcontrib><creatorcontrib>Guh, Jinn-Yuh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><creatorcontrib>Hung, Wen-Chun</creatorcontrib><creatorcontrib>Lai, Yung-Hsiung</creatorcontrib><creatorcontrib>Chuang, Lea-Yea</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Jau-Shyang</au><au>Guh, Jinn-Yuh</au><au>Chen, Hung-Chun</au><au>Hung, Wen-Chun</au><au>Lai, Yung-Hsiung</au><au>Chuang, Lea-Yea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>81</volume><issue>1</issue><spage>102</spage><epage>113</epage><pages>102-113</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>11180401</pmid><doi>10.1002/1097-4644(20010401)81:1&lt;102::AID-JCB1027&gt;3.0.CO;2-Y</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2001-01, Vol.81 (1), p.102-113
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_70611811
source MEDLINE; Wiley Online Library All Journals
subjects advanced glycation end-product
Base Sequence
captopril
Captopril - pharmacology
Cell Line
Collagen - biosynthesis
diabetic nephropathy
DNA Primers
DNA-Binding Proteins - metabolism
Dose-Response Relationship, Drug
Down-Regulation - drug effects
Glycation End Products, Advanced
Janus Kinase 2
Kinetics
oligodeoxynucleotide
Oligonucleotides, Antisense - pharmacology
Phosphorylation
Protein-Tyrosine Kinases - metabolism
Proto-Oncogene Proteins
Receptor for Advanced Glycation End Products
Receptors, Immunologic - genetics
Receptors, Immunologic - metabolism
Signal Transduction
STAT1 Transcription Factor
STAT3 Transcription Factor
Trans-Activators - metabolism
Tyrosine - metabolism
tyrosine phosphorylation
Tyrphostins - pharmacology
title Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A56%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20receptor%20for%20advanced%20glycation%20end-product%20(RAGE)%20and%20the%20JAK/STAT-signaling%20pathway%20in%20AGE-induced%20collagen%20production%20in%20NRK-49F%20cells&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Huang,%20Jau-Shyang&rft.date=2001-01-01&rft.volume=81&rft.issue=1&rft.spage=102&rft.epage=113&rft.pages=102-113&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/1097-4644(20010401)81:1%3C102::AID-JCB1027%3E3.0.CO;2-Y&rft_dat=%3Cproquest_cross%3E70611811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70611811&rft_id=info:pmid/11180401&rfr_iscdi=true